Eleven states that were not part of the initial 32-state probe have also filed
lawsuits over the atypical antipsychotic medication, which the company launched
in 1996. …
scientists in the company and collaborators in the US and Canada found that the
drug was transported rapidly across the blood-brain barrier and into the
functional part of the brain, the parenchyma. …
There’s nothing more sacred than the physician-patient relationship, and we
physicians have the responsibility to make sure nothing gets in the way of that
relationship–or even appears to get in the way.” …